extends: existence
message: "Required Phase 3 element missing: %s"
level: error
tokens:
  # Primary Analysis Elements
  - confirmatory efficacy analysis with pre-specified hypothesis
  - non-inferiority margin with clinical justification
  - superiority margin with effect size rationale
  - multiplicity adjustment with FWER control
  - interim analysis with alpha spending
  - sample size re-estimation criteria
  - missing data approach with sensitivity
  - estimand framework with ICE strategy
  - subgroup analysis with interaction testing
  - multicenter analysis with poolability
  - covariate adjustment with specification
  - stratification factors with rationale
  
  # Long-term Safety Elements
  - cumulative exposure assessment
  - time-dependent AE analysis
  - laboratory trend evaluation
  - vital sign monitoring strategy
  - ECG interval analysis
  - immunogenicity assessment
  - pregnancy surveillance
  - pediatric safety monitoring
  - geriatric safety profile
  - organ impairment safety
  - drug-drug interaction profile
  - QT/QTc evaluation strategy
  
  # Quality of Life Elements
  - PRO instrument validation
  - HRQL domain assessment
  - functional status measures
  - symptom burden evaluation
  - treatment satisfaction
  - caregiver burden assessment
  - productivity impact
  - healthcare utilization
  
  # Population Elements
  - demographic representation
  - ethnic factor analysis
  - geographic diversity
  - age group stratification
  - comorbidity assessment
  - concomitant medication impact
  - compliance monitoring
  - discontinuation patterns
  - lost to follow-up analysis
  
  # Regulatory Elements
  - registration trial requirements
  - marketing application strategy
  - labeling considerations
  - risk evaluation strategy
  - post-marketing commitments
  - pediatric investigation plan
  - special population requirements
  - regional regulatory alignment
  - advisory committee preparation
  
  # Comparative Elements
  - active control justification
  - historical evidence synthesis
  - assay sensitivity demonstration
  - constancy assumption validation
  - bridge study requirements
  - therapeutic equivalence bounds
  - comparative safety analysis
  - comparative effectiveness
  - cost-effectiveness analysis
  
  # Implementation Elements
  - site selection criteria
  - investigator qualifications
  - monitoring strategy
  - data quality metrics
  - protocol compliance measures
  - GCP inspection readiness
  - safety reporting procedures
  - database lock criteria
  - blind maintenance procedures
  
  # Analysis Strategy
  - primary analysis method
  - sensitivity analysis plan
  - missing data handling
  - intercurrent events
  - multiplicity control
  - interim analyses
  - subgroup analyses
  - safety analyses
  - PK/PD analyses
